Search for: "In Re Phenylpropanolamine (Ppa) Products" Results 1 - 16 of 16
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
10 Nov 2020, 1:06 pm by admin
” Something akin to hacking the A cell occurred in the large epidemiologic study, known as  “Yale Hemorrhagic Stroke Project (HSP),” which was the center piece of the plaintiffs’ case in In re Phenylpropanolamine Products Liability Litigation. [read post]
10 Nov 2020, 5:06 am by Schachtman
” Something akin to hacking the A cell occurred in the large epidemiologic study, known as  “Yale Hemorrhagic Stroke Project (HSP),” which was the center piece of the plaintiffs’ case in In re Phenylpropanolamine Products Liability Litigation. [read post]
28 May 2020, 5:29 am by Schachtman
Despite the confusing verbiage, these judicial rulings are a serious deviation from the text of Rule 702, as well as the Advisory Committee Note to the 2000 Amendments, which embraced the standard articulated in In re Paoli, that “any step that renders the analysis unreliable . . . renders the expert’s testimony inadmissible. [read post]
25 Apr 2013, 5:00 am by Bexis
Ohio 2009) warranty; privityIn re Zyprexa Products Liability Litigation, 649 F. [read post]
14 Jul 2012, 7:08 am by Schachtman
Id. citing In re Phenylpropanolamine (PPA) Prods. [read post]
29 Feb 2012, 8:25 am by Schachtman
See In re Phenylpropanolamine (PPA) Prods. [read post]
1 Feb 2012, 11:15 am by Sean Wajert
La. 2006)(citing In re Phenylpropanolamine (PPA) Prods. [read post]
14 Aug 2011, 9:11 am by Schachtman
Merrell challenged Swan’s unpublished, non-peer-reviewed re-analyses as not “generally accepted” under the Frye test.  [read post]
27 Aug 2010, 2:41 pm by Bexis
If the manufacturer designs the product safely, manufactures the product safely, and provides an adequate warning of dangers inherent in the use of the product, then a failure to test the product cannot, standing alone, cause any injury. [read post]
24 Jun 2010, 5:00 am by Bexis
Kan. 1996).In re Norplant Contraceptive Products Liability Litigation, 168 F.R.D. 577 (E.D. [read post]
17 Jul 2009, 3:45 am
Mar. 18, 2002) and In re Phenylpropanolamine (PPA) Products Liability Litigation, MDL No. 1407, Case Management Order No. 6 (W.D. [read post]
11 Aug 2008, 12:30 pm
See, e.g., In re Phenylpropanolamine (PPA) Prods. [read post]
16 Jul 2008, 12:00 pm
Jude Medical, Inc., Silzone Heart Valves Products Liability LitigationMDL-1401 IN RE Sulzer Orthopedics, Inc., Hip Prosthesis and Knee Prosthesis Products Liability LitigationMDL-1407 IN RE Phenylpropanolamine (PPA) Products Liability LitigationMDL-1431 IN RE Baycol Products Liability LitigationMDL-1477 IN RE Serzone Products Liability LitigationMDL-1481 IN RE Meridia Products… [read post]
25 Mar 2007, 2:18 am
We're big fans of the preemption defense in prescription drug cases. [read post]
30 Aug 2006, 6:00 am
In In re Phenylpropanolamine (PPA) Products Liability Litigation, ___ F.3d ___ (Aug. 29, 2006), the Ninth Circuit addressed multidistrict litigation ("MDL") proceedings under 28 U.S.C. section 1407. [read post]